Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

NCT04599218 is registered in ClinicalTrials.gov with Ardeshir Rastinehad as lead sponsor.

NCT NCT04599218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04599218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
Lead sponsor
Ardeshir Rastinehad
Phase
Not applicable
Overall status
Unknown status
Start date
August 21, 2020
Completion date
January 15, 2026
Enrollment
1,586 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

elevated prostate specific antigen, family history of prostate cancer, positive digital rectal exam, prostate cancer, prostate disease